A Phase I, Open-label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Oral Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function.
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2014
At a glance
- Drugs Panobinostat (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2012 Planned number of patients changed from 32 to 24 as reported by ClinicalTrials.gov.
- 09 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.